GlassScriptPhysician profile
Saqib B Khan
NPI 1790745875
$4,659.64
in general payments reported to CMS, 2019-2025
25 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $27.43 · 2021: $109 · 2022: $2,071 · 2023: $828 · 2024: $699 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,089.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,421.13 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Activos 10 Bone Cement |
| Abbott Laboratories | $870.48 | 2022-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $237.23 | 2019-2025 | Clik X, Wavewriter Alpha Prime 16, Infinion 16 |
| Vertos Medical, INC. | $230.21 | 2023-2024 | Mild Device Kit |
| Medtronic USA, INC. | $211.68 | 2019-2020 | |
| Nevro Corp. | $155.39 | 2019-2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $77.70 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.75 | 2022-2025 | Relistor |
| Protega Pharmaceutials INC | $52.14 | 2025 | Roxybond |
| Flowonix Medical Incorporated | $43.05 | 2019 | |
| Valinor Pharma, LLC | $36.13 | 2025 | Movantik |
| Si-Bone, INC. | $32.83 | 2025 | |
| Spinal Simplicity, LLC | $26.33 | 2025 | Ha Minuteman G3-R |
| Tersera Therapeutics LLC | $26.01 | 2025 | Prialt |
| Averitas Pharma INC. | $23.94 | 2025 | Qutenza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $20.13 | 2024 | |
| Tonix Medicines, INC. | $19.36 | 2025 | Tonmya |
| Spr Therapeutics, INC | $17.67 | 2023 | Sprint Pns System |
| Genzyme Corporation | $17.43 | 2024 | |
| Nalu Medical, INC. | $14.49 | 2021 | |
| Convatec INC. | $14.22 | 2023 | |
| Piramal Critical Care | $13.59 | 2022 | |
| Eisai INC. | $12.95 | 2020 | |
| Hikma Pharmaceuticals USA | $11.77 | 2022 | |
| Foundation Fusion Solutions, LLC | $11.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saqib Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.